Vimarsana
Biggest News Aggregation in the World

Page 4 - Lead Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lead Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lead Program Today - Breaking & Trending Today

Absa 2022 Graduate Talent Program for young Kenyan graduates | Opportunities For Africans - Vimarsana News

Absa 2022 Graduate Talent Program for young Kenyan graduates | Opportunities For Africans

Absa 2022 Graduate Talent Program for young Kenyan graduates Application Deadline: 15th December 2021

Biotechnology (Science) News | Latest News - Vimarsana News

Biotechnology (Science) News | Latest News

The latest news on the science of Biotechnology, from the best sources of Biotechnology news. Get the latest Biotechnology news now.

Avidity Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights - Vimarsana News

Avidity Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights

/PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody...

Sunflowers and Hemp Could Reduce Lead in Burlington Soil - Vimarsana News

Sunflowers and Hemp Could Reduce Lead in Burlington Soil

A monarch butterfly on a sunflower When Laura Hill bought a house in Burlington's Old North End, she was warned about the lead. Until it was banned in the U.S. in 1978, lead paint was used in many homes. Lead remediation had been done inside the home, but Hill said there were likely still high levels of lead on and around the outside walls and in the soil. "It struck me, because it was my neighborhood and I saw people growing food in their yards next to their house," she said. Hill is a plant biologist and senior lecturer at the University of V...

Avidity Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Highlights - Vimarsana News

Avidity Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Highlights

Share this article Share this article LA JOLLA, Calif., March 15, 2021 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs™), today reported financial results for the fourth quarter and year ended December 31, 2020 and highlighted recent corporate progress.        "In 2020, we made significant advances across our AOC pipeline and platform. Our work supports Avidity's evolution to a clinical-stage company as we plan to advance AOC 1001 into the cli...